Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam vs meropenem for empirical treatment of febrile neutropenia in hematologic patients
TCTR20180109001Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jan 2016
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of piperacillin + tazobactam and meropenem in febrile neutropenia (FN) and hematopoietic malignancies (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jan 2016; status: completed.
02
Drugs
piperacillin + tazobactammeropenem
03
Conditions
febrile neutropenia (FN)hematopoietic malignancies
Beyond the preview
Go deeper on TCTR20180109001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180109001.